Published in Nephron Clin Pract on January 20, 2010
Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequences. BMC Nephrol (2011) 0.85
Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes. Kidney Int (2012) 0.84
Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise. Pharmacogenet Genomics (2012) 0.84
Genetic predisposition to acute kidney injury - a systematic review. BMC Nephrol (2015) 0.81
CYBA Gene Polymorphisms and Adverse Outcomes in Acute Kidney Injury: A Prospective Cohort Study. Nephron Extra (2011) 0.81
Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury. Nephron Clin Pract (2013) 0.80
Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a case-control and longitudinal cohort study. Nephron Clin Pract (2013) 0.76
AKI and Genetics: Evolving Concepts in the Genetics of Acute Kidney Injury: Implications for Pediatric AKI. J Pediatr Genet (2015) 0.75
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Pyrosequencing sheds light on DNA sequencing. Genome Res (2001) 11.87
Hospital-acquired renal insufficiency. Am J Kidney Dis (2002) 7.90
Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int (2004) 6.04
Haplotype reconstruction from genotype data using Imperfect Phylogeny. Bioinformatics (2004) 6.02
Hospital-acquired renal insufficiency: a prospective study. Am J Med (1983) 5.15
Stress hormones: their interaction and regulation. Science (1984) 2.53
Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med (2001) 2.17
Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol (2008) 1.68
Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol (2009) 1.60
NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol (2006) 1.46
Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension (2007) 1.09
Epinephrine biosynthesis: hormonal and neural control during stress. Cell Mol Neurobiol (2006) 0.92
Clinical catecholamine neurochemistry: a legacy of Julius Axelrod. Cell Mol Neurobiol (2006) 0.85
Structure of human phenylethanolamine n-methyltransferase gene: existence of two types of mRNA with different transcription initiation sites. Neurochem Int (1989) 0.84
Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol (2005) 6.27
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
The chromogranin-secretogranin family. N Engl J Med (2003) 4.28
CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell (2006) 4.10
Incidence and prevalence of hyponatremia. Am J Med (2006) 3.61
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol (2013) 2.83
Dimorphic effects of Notch signaling in bone homeostasis. Nat Med (2008) 2.82
Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med (2010) 2.67
Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med (2012) 2.43
Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production. Cell Host Microbe (2010) 2.39
Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol (2003) 2.31
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis (2008) 2.31
Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A (2006) 2.23
Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest (2005) 2.19
Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation (2012) 2.14
Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis (2008) 2.10
Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels. Kidney Int (2013) 2.05
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation (2007) 1.91
The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol (2008) 1.79
Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers (2009) 1.77
Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol (2012) 1.69
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis (2012) 1.69
Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol (2008) 1.68
At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int (2012) 1.68
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens (2009) 1.66
Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension (2006) 1.64
Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension (2006) 1.61
Autonomic and hemodynamic origins of pre-hypertension: central role of heredity. J Am Coll Cardiol (2012) 1.59
Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet (2004) 1.58
Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis. J Am Soc Nephrol (2009) 1.55
Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses. J Hypertens (2010) 1.54
Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat Med (2011) 1.54
Epidemiology of hyponatremia. Semin Nephrol (2009) 1.52
Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension (2005) 1.52
Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics (2004) 1.51
Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol Dial Transplant (2009) 1.49
A common genetic variant in the 3'-UTR of vacuolar H+-ATPase ATP6V0A1 creates a micro-RNA motif to alter chromogranin A processing and hypertension risk. Circ Cardiovasc Genet (2011) 1.47
NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol (2006) 1.46
Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traits. Kidney Int (2009) 1.44
Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis (2004) 1.43
Relationship of urine output to dialysis initiation and mortality in acute renal failure. Nephron Clin Pract (2004) 1.41
Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure. J Hypertens (2012) 1.41
ARF after open-heart surgery: Influence of gender and race. Am J Kidney Dis (2003) 1.41
Ongoing clinical trials in AKI. Clin J Am Soc Nephrol (2012) 1.38
Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. J Vasc Surg (2006) 1.37
GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis (2012) 1.35
Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation (2007) 1.32
miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet (2012) 1.31
Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension (2012) 1.28
The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin A null mouse. J Neurosci (2008) 1.28
The International Endogene Study: a collection of families for genetic research in endometriosis. Fertil Steril (2002) 1.28
Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension (2006) 1.27
Dysregulation of chondrogenesis in human cleidocranial dysplasia. Am J Hum Genet (2005) 1.27
AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol (2013) 1.26
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest (2007) 1.25
Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology (2011) 1.24
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int (2002) 1.24
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2005) 1.21
Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. Gastroenterology (2010) 1.20
Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens (2009) 1.20
Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis. Am J Kidney Dis (2012) 1.17
Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials. Clin J Am Soc Nephrol (2010) 1.17
Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine (2004) 1.15